SK63595A3 - Acylo aminoalkyl imidazole derivatives and -triazoles, method of their preparation and pharmaceutical agent containing them - Google Patents

Acylo aminoalkyl imidazole derivatives and -triazoles, method of their preparation and pharmaceutical agent containing them

Info

Publication number
SK63595A3
SK63595A3 SK635-95A SK63595A SK63595A3 SK 63595 A3 SK63595 A3 SK 63595A3 SK 63595 A SK63595 A SK 63595A SK 63595 A3 SK63595 A3 SK 63595A3
Authority
SK
Slovakia
Prior art keywords
acylo
triazoles
preparation
agent containing
pharmaceutical agent
Prior art date
Application number
SK635-95A
Other languages
Slovak (sk)
Other versions
SK280326B6 (en
Inventor
Ingeborg Schuster
Helmut Egger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SK63595A3 publication Critical patent/SK63595A3/en
Publication of SK280326B6 publication Critical patent/SK280326B6/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention concerns azole compounds of formula <CHEM> wherein the substituents have various significances, in free form or salt form. They can be prepared e.g. by acylation, or by aziridine or oxazole ring opening. The compounds can be used as pharmaceuticals, especially as selective inhibitors of the 25-hydroxyvitamin D3 - hydroxylases in the treatment of disorders of proliferation and differentiation in vitamin D - responsive tissues.
SK635-95A 1994-05-18 1995-05-16 Acylated aminoalkanimidazoles and -triazoles derivatives, method of their preparation, pharmaceutical composition them containing SK280326B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409882A GB9409882D0 (en) 1994-05-18 1994-05-18 Organic compounds

Publications (2)

Publication Number Publication Date
SK63595A3 true SK63595A3 (en) 1995-12-06
SK280326B6 SK280326B6 (en) 1999-11-08

Family

ID=10755289

Family Applications (1)

Application Number Title Priority Date Filing Date
SK635-95A SK280326B6 (en) 1994-05-18 1995-05-16 Acylated aminoalkanimidazoles and -triazoles derivatives, method of their preparation, pharmaceutical composition them containing

Country Status (30)

Country Link
US (1) US5622982A (en)
EP (1) EP0683156B1 (en)
JP (1) JP2912566B2 (en)
KR (1) KR100371465B1 (en)
CN (1) CN1060163C (en)
AT (1) ATE164576T1 (en)
AU (1) AU696880B2 (en)
BR (1) BR9502062A (en)
CA (1) CA2149459C (en)
CO (1) CO4290423A1 (en)
CZ (1) CZ285385B6 (en)
DE (1) DE69501915T2 (en)
DK (1) DK0683156T3 (en)
ES (1) ES2114289T3 (en)
FI (1) FI112364B (en)
GB (1) GB9409882D0 (en)
GR (1) GR3026505T3 (en)
HK (1) HK1008743A1 (en)
HU (1) HUT72063A (en)
IL (1) IL113743A (en)
MY (1) MY135559A (en)
NO (1) NO304738B1 (en)
NZ (1) NZ272129A (en)
PE (1) PE14896A1 (en)
PH (1) PH31510A (en)
RU (1) RU2152933C2 (en)
SI (1) SI0683156T1 (en)
SK (1) SK280326B6 (en)
TW (1) TW351718B (en)
ZA (1) ZA954074B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869499A (en) * 1993-07-15 1999-02-09 Pfizer Inc Benzyloxyquinuclidines as substance P antagonists
WO1997018817A1 (en) * 1995-11-20 1997-05-29 Kiyoshi Kita External preparation containing vitamin d or vitamin k
WO1998053806A1 (en) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
TW575562B (en) * 1998-02-19 2004-02-11 Agrevo Uk Ltd Fungicides
IL129596A (en) * 1998-05-08 2003-10-31 Dow Agrosciences Llc Preparation of 2-substituted pyridines
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
WO2006036892A2 (en) * 2004-09-24 2006-04-06 Sapphire Therapeutics, Inc. Use of inhibitors of 24-hydroxylase in the treatment of cancer
WO2006032299A1 (en) * 2004-09-24 2006-03-30 Susanna Miettinen Use of inhibitors of 24-hydroxylase in the treatment of cancer
CN104530038A (en) * 2014-12-10 2015-04-22 沈阳药科大学 Amide imidazole derivative and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (en) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivatives
US4191767A (en) * 1977-01-07 1980-03-04 Westwood Pharmaceuticals, Inc. Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines
CH655103A5 (en) * 1983-03-11 1986-03-27 Sandoz Ag AZOLE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE.
CH677925A5 (en) * 1986-12-03 1991-07-15 Sandoz Ag

Also Published As

Publication number Publication date
HU9501451D0 (en) 1995-06-28
JPH0853422A (en) 1996-02-27
EP0683156B1 (en) 1998-04-01
RU2152933C2 (en) 2000-07-20
IL113743A (en) 1999-08-17
CZ285385B6 (en) 1999-07-14
CZ126595A3 (en) 1995-11-15
DE69501915D1 (en) 1998-05-07
NO304738B1 (en) 1999-02-08
ATE164576T1 (en) 1998-04-15
NO951944D0 (en) 1995-05-16
KR950032147A (en) 1995-12-20
PE14896A1 (en) 1996-05-09
EP0683156A1 (en) 1995-11-22
CO4290423A1 (en) 1996-04-17
RU95107652A (en) 1997-03-20
DE69501915T2 (en) 1998-08-27
SK280326B6 (en) 1999-11-08
MY135559A (en) 2008-05-30
FI112364B (en) 2003-11-28
FI952383A (en) 1995-11-19
CN1060163C (en) 2001-01-03
AU696880B2 (en) 1998-09-24
TW351718B (en) 1999-02-01
KR100371465B1 (en) 2003-03-19
JP2912566B2 (en) 1999-06-28
SI0683156T1 (en) 1998-06-30
GR3026505T3 (en) 1998-07-31
DK0683156T3 (en) 1998-10-19
AU2008995A (en) 1995-11-23
ZA954074B (en) 1996-11-18
NZ272129A (en) 1996-05-28
GB9409882D0 (en) 1994-07-06
US5622982A (en) 1997-04-22
CN1120039A (en) 1996-04-10
HK1008743A1 (en) 1999-05-14
HUT72063A (en) 1996-03-28
NO951944L (en) 1995-11-20
CA2149459A1 (en) 1995-11-19
ES2114289T3 (en) 1998-05-16
PH31510A (en) 1998-11-03
BR9502062A (en) 1996-04-30
CA2149459C (en) 2006-09-19
FI952383A0 (en) 1995-05-16
IL113743A0 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
GB9715894D0 (en) Heterocyclic derivatives
SK63595A3 (en) Acylo aminoalkyl imidazole derivatives and -triazoles, method of their preparation and pharmaceutical agent containing them
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
SE9903997D0 (en) New compounds
NZ304291A (en) Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof
DE69008142D1 (en) 4-substituted imidazoles for lowering intraocular pressure.
GB9505082D0 (en) Medicament
GR930300124T1 (en) Bile acid sulfurated derivatives
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance
HUP9801596A3 (en) Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them
DE69905524T2 (en) 8H- (2,3-b) -pyrrolozin-8-one derivatives, process for their preparation and pharmaceutical compositions containing them
DE59405726D1 (en) (THIO) CARBAMIDIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100516